CSIMarket
 


Becton Dickinson And Company  (BDX)
Other Ticker:  
 
 

BDX's Revenue Growth by Quarter and Year

Becton Dickinson And's Revenue results by quarter and year




BDX Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter September 5,087.00 4,223.00 5,136.00 4,784.00
III Quarter June 4,878.00 4,641.00 4,890.00 3,855.00
II Quarter March 4,821.00 5,011.00 4,907.00 4,253.00
I Quarter December 4,586.00 4,995.00 5,315.00 4,225.00
FY   19,372.00 18,870.00 20,248.00 17,117.00



BDX Revenue fourth quarter 2023 Y/Y Growth Comment
Becton Dickinson And Company achieved in the fourth quarter 2023, above Company average Revenue growth of 20.46% year on year, to $ 5,087.00 millions.

Looking into fourth quarter 2023 results within Medical Equipment & Supplies industry 41 other companies have achieved higher Revenue growth. While Becton Dickinson And Company' s Revenue rise of 20.46% ranks overall at the positon no. 637 in the fourth quarter 2023.




BDX Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter September 20.46 % -17.78 % 7.36 % 4.34 %
III Quarter June 5.11 % -5.09 % 26.85 % -11.38 %
II Quarter March -3.79 % 2.12 % 15.38 % 1.38 %
I Quarter December -8.19 % -6.02 % 25.8 % 1.56 %
FY   2.66 % -6.81 % 18.29 % -1 %

Financial Statements
Becton Dickinson And's fourth quarter 2023 Revenue $ 5,087.00 millions BDX's Income Statement
Becton Dickinson And's fourth quarter 2022 Revenue $ 4,223.00 millions Quarterly BDX's Income Statement
New: More BDX's historic Revenue Growth >>


BDX Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter September 4.28 % -9.01 % 5.03 % 24.1 %
III Quarter June 1.18 % -7.38 % -0.35 % -9.36 %
II Quarter March 5.12 % 0.32 % -7.68 % 0.66 %
I Quarter December 8.6 % -2.75 % 11.1 % -7.85 %
FY (Year on Year)   2.66 % -6.81 % 18.29 % -1 %




Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #42
Healthcare Sector #180
Overall #637

Revenue Y/Y Growth Statistics
High Average Low
132.11 % 8.79 % -36.76 %
(Sep 30 2015)   (Sep 30 2016)
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #42
Healthcare Sector #180
Overall #637
Revenue Y/Y Growth Statistics
High Average Low
132.11 % 8.79 % -36.76 %
(Sep 30 2015)   (Sep 30 2016)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Becton Dickinson And's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
63.81 % 2.52 % -41.58 %
(Sep 30 2015)  


BDX's IV. Quarter Q/Q Revenue Comment
Becton Dickinson And Company achieved in the IV. Quarter 2023 above company average sequential Revenue growth of 4.28%, to $ 5,087.00 millions, from $4,878.00 millions in the third quarter.
Becton Dickinson And is undergoing a remarkable growth, not just claiming higher then average increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 36 other companies have achieved higher Revenue quarter on quarter growth. While Becton Dickinson And's Revenue growth quarter on quarter, overall rank is 1084.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #37
Healthcare Sector #224
Overall #1084
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #37
Healthcare Sector #224
Overall #1084
Revenue Q/Q Growth Statistics
High Average Low
63.81 % 2.52 % -41.58 %
(Sep 30 2015)  


BDX's IV. Quarter Q/Q Revenue Comment
Becton Dickinson And Company achieved in the IV. Quarter 2023 above company average sequential Revenue growth of 4.28%, to $ 5,087.00 millions, from $4,878.00 millions in the third quarter.
BDX is going from strength to strength, not just reporting better then regular gain, and also improving pace, Alma Jonsson, Medical Equipment & Supplies industry advisor based in Malmo mentioned.

Within Medical Equipment & Supplies industry 36 other companies have achieved higher Revenue quarter on quarter growth. While Becton Dickinson And's Revenue growth quarter on quarter, overall rank is 1084.


Becton Dickinson And's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 19,372.00 $ 18,508.00 $ 18,271.00 $ 18,461.00 $ 18,870.00
Y / Y Revenue Growth (TTM) 2.66 % -6.44 % -8.79 % -7.36 % -6.81 %
Year on Year Revenue Growth Overall Ranking # 2329 # 1220 # 1472 # 1321 # 2551
Seqeuential Revenue Change (TTM) 4.67 % 1.3 % -1.03 % -2.17 % -4.62 %
Seq. Revenue Growth (TTM) Overall Ranking # 2235 # 2081 # 1819 # 1902 # 2985




Cumulative Revenue growth Comment
Although Becton Dickinson And's Annual Revenue growth year on year were below company's average 6.92% , Revenue announced in the Sep 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 2.66% year on year, from -6.44% in Jun 30 2023.

In the Healthcare sector 377 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1220 to 2329.

Revenue TTM Q/Q Growth Statistics
High Average Low
68.82 %
6.92 %
-15.35 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 112
Healthcare Sector # 378
Overall # 2329

Revenue TTM Y/Y Growth Statistics
High Average Low
68.82 %
6.92 %
-15.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 112
Sector # 367
S&P 500 # 2235
Cumulative Revenue growth Comment
Although Becton Dickinson And's Annual Revenue growth year on year were below company's average 6.92% , Revenue announced in the Sep 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 2.66% year on year, from -6.44% in Jun 30 2023.

In the Healthcare sector 377 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1220 to 2329.

Revenue TTM Q/Q Growth Statistics
High Average Low
68.82 %
6.92 %
-15.35 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 112
Healthcare Sector # 378
Overall # 2329

Revenue TTM Y/Y Growth Statistics
High Average Low
68.82 %
6.92 %
-15.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 112
Sector # 367
S&P 500 # 2235




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BDX's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for BDX's Competitors
Revenue Growth for Becton Dickinson And's Suppliers
Revenue Growth for BDX's Customers

You may also want to know
BDX's Annual Growth Rates BDX's Profitability Ratios BDX's Asset Turnover Ratio BDX's Dividend Growth
BDX's Roe BDX's Valuation Ratios BDX's Financial Strength Ratios BDX's Dividend Payout Ratio
BDX's Roa BDX's Inventory Turnover Ratio BDX's Growth Rates BDX's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Lantheus Holdings Inc 33.29%$ 33.289 millions
Lifeloc Technologies Inc 32.66%$ 32.662 millions
Nephros Inc 32.59%$ 32.586 millions
Alphatec Holdings Inc 31.40%$ 31.398 millions
Axonics Inc 30.86%$ 30.859 millions
Inari Medical Inc 30.86%$ 30.856 millions
Rockwell Medical inc 30.52%$ 30.517 millions
Tela Bio Inc 30.05%$ 30.052 millions
Rapid Micro Biosystems Inc 29.67%$ 29.669 millions
Ontrak Inc 29.26%$ 29.265 millions
Adaptimmune Therapeutics Plc29.15%$ 29.150 millions
Bionano Genomics Inc 29.04%$ 29.040 millions
Talkspace Inc 29.04%$ 29.037 millions
Akoya Biosciences Inc 28.77%$ 28.771 millions
Neurocrine Biosciences Inc 28.59%$ 28.590 millions
Si bone inc 28.53%$ 28.530 millions
Medpace Holdings Inc 28.34%$ 28.341 millions
Caremax Inc 28.02%$ 28.016 millions
Acutus Medical Inc 27.41%$ 27.415 millions
Natera Inc 27.38%$ 27.378 millions
Urogen Pharma Ltd 27.26%$ 27.260 millions
Seagen Inc 27.11%$ 27.112 millions
Insulet Corporation26.97%$ 26.966 millions
Penumbra Inc26.80%$ 26.801 millions
Dexcom Inc 26.60%$ 26.598 millions
Lensar Inc 26.42%$ 26.420 millions
The Oncology Institute Inc 26.25%$ 26.252 millions
Pulmonx Corporation26.12%$ 26.122 millions
Ocular Therapeutix Inc 26.04%$ 26.043 millions
Theravance Biopharma inc 26.04%$ 26.038 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com